Salivary proteomics profiling reveals potential biomarkers for chronic kidney disease: a pilot study

IntroductionChronic kidney disease (CKD) is a global public health problem, and the absence of reliable and accurate diagnostic and monitoring tools contributes to delayed treatment, impacting patients’ quality of life and increasing treatment costs in public health. Proteomics using saliva is a key...

Full description

Saved in:
Bibliographic Details
Main Authors: Bianca Uliana Picolo, Nathália Rabello Silva, Mário Machado Martins, Hebréia Oliveira Almeida-Souza, Letícia Cristina Machado de Sousa, Richard Costa Polveiro, Luiz Ricardo Goulart Filho, Robinson Sabino-Silva, Vivian Alonso-Goulart, Luciana Saraiva da Silva
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1302637/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841525326851604480
author Bianca Uliana Picolo
Nathália Rabello Silva
Mário Machado Martins
Hebréia Oliveira Almeida-Souza
Letícia Cristina Machado de Sousa
Richard Costa Polveiro
Luiz Ricardo Goulart Filho
Robinson Sabino-Silva
Vivian Alonso-Goulart
Luciana Saraiva da Silva
author_facet Bianca Uliana Picolo
Nathália Rabello Silva
Mário Machado Martins
Hebréia Oliveira Almeida-Souza
Letícia Cristina Machado de Sousa
Richard Costa Polveiro
Luiz Ricardo Goulart Filho
Robinson Sabino-Silva
Vivian Alonso-Goulart
Luciana Saraiva da Silva
author_sort Bianca Uliana Picolo
collection DOAJ
description IntroductionChronic kidney disease (CKD) is a global public health problem, and the absence of reliable and accurate diagnostic and monitoring tools contributes to delayed treatment, impacting patients’ quality of life and increasing treatment costs in public health. Proteomics using saliva is a key strategy for identifying potential disease biomarkers.MethodsWe analyzed the untargeted proteomic profiles of saliva samples from 20 individuals with end-stage kidney disease (ESKD) (n = 10) and healthy individuals (n = 10) using liquid chromatography–tandem mass spectrometry (LC–MS/MS) to identify potential biomarkers for CKD. A volcano plot was generated using a p-value of ≤0.05 and a fold change (FC) ≥ 2.0. Multivariate analysis was performed to generate the orthogonal partial least squares discriminant analysis (OPLS-DA) model and the variable importance in projection (VIP) scores. The accuracy of candidate biomarker proteins was evaluated using receiver operating characteristic (ROC) curves.ResultsIn total, 431 proteins were identified in the salivary proteomic profile, and 3 proteins were significantly different between the groups: apoptosis inhibitor 5 (API5), phosphoinositide phospholipase C (PI-PLC), and small G protein signaling modulator 2 (Sgsm2). These proteins showed good accuracy based on the ROC curve and a VIP score of >2.0. During pathway enrichment, PI-PLC participates in the synthesis of IP3 and IP4 in the cytosol. Gene ontology (GO) analysis revealed data on molecular functions, biological processes, cellular components, and protein classes.ConclusionWe can conclude that the salivary API5, PI-PLC, and Sgsm2 can be potential biomarker candidates for CKD detection. These proteins may participate in pathways related to renal fibrosis and other associated diseases, such as mineral and bone disorders.
format Article
id doaj-art-c827b17cceba44798829e41f7c9b2891
institution Kabale University
issn 2296-858X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-c827b17cceba44798829e41f7c9b28912025-01-17T15:54:56ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-01-011110.3389/fmed.2024.13026371302637Salivary proteomics profiling reveals potential biomarkers for chronic kidney disease: a pilot studyBianca Uliana Picolo0Nathália Rabello Silva1Mário Machado Martins2Hebréia Oliveira Almeida-Souza3Letícia Cristina Machado de Sousa4Richard Costa Polveiro5Luiz Ricardo Goulart Filho6Robinson Sabino-Silva7Vivian Alonso-Goulart8Luciana Saraiva da Silva9Laboratory of Nanobiotechnology Prof. Dr. Luiz Ricardo Goulart Filho, Institute of Biotechnology, Federal University of Uberlândia, Uberlândia, BrazilFaculty of Medicine, Federal University of Uberlândia, Uberlândia, BrazilLaboratory of Nanobiotechnology Prof. Dr. Luiz Ricardo Goulart Filho, Institute of Biotechnology, Federal University of Uberlândia, Uberlândia, BrazilLaboratory of Nanobiotechnology Prof. Dr. Luiz Ricardo Goulart Filho, Institute of Biotechnology, Federal University of Uberlândia, Uberlândia, BrazilFaculty of Medicine, Federal University of Uberlândia, Uberlândia, BrazilFaculty of Veterinary Medicine and Animal Science, Federal University of Uberlândia, Uberlândia, BrazilLaboratory of Nanobiotechnology Prof. Dr. Luiz Ricardo Goulart Filho, Institute of Biotechnology, Federal University of Uberlândia, Uberlândia, BrazilInnovation Center in Salivary Diagnostic and Nanobiotechnology, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, BrazilLaboratory of Nanobiotechnology Prof. Dr. Luiz Ricardo Goulart Filho, Institute of Biotechnology, Federal University of Uberlândia, Uberlândia, BrazilFaculty of Medicine, Federal University of Uberlândia, Uberlândia, BrazilIntroductionChronic kidney disease (CKD) is a global public health problem, and the absence of reliable and accurate diagnostic and monitoring tools contributes to delayed treatment, impacting patients’ quality of life and increasing treatment costs in public health. Proteomics using saliva is a key strategy for identifying potential disease biomarkers.MethodsWe analyzed the untargeted proteomic profiles of saliva samples from 20 individuals with end-stage kidney disease (ESKD) (n = 10) and healthy individuals (n = 10) using liquid chromatography–tandem mass spectrometry (LC–MS/MS) to identify potential biomarkers for CKD. A volcano plot was generated using a p-value of ≤0.05 and a fold change (FC) ≥ 2.0. Multivariate analysis was performed to generate the orthogonal partial least squares discriminant analysis (OPLS-DA) model and the variable importance in projection (VIP) scores. The accuracy of candidate biomarker proteins was evaluated using receiver operating characteristic (ROC) curves.ResultsIn total, 431 proteins were identified in the salivary proteomic profile, and 3 proteins were significantly different between the groups: apoptosis inhibitor 5 (API5), phosphoinositide phospholipase C (PI-PLC), and small G protein signaling modulator 2 (Sgsm2). These proteins showed good accuracy based on the ROC curve and a VIP score of >2.0. During pathway enrichment, PI-PLC participates in the synthesis of IP3 and IP4 in the cytosol. Gene ontology (GO) analysis revealed data on molecular functions, biological processes, cellular components, and protein classes.ConclusionWe can conclude that the salivary API5, PI-PLC, and Sgsm2 can be potential biomarker candidates for CKD detection. These proteins may participate in pathways related to renal fibrosis and other associated diseases, such as mineral and bone disorders.https://www.frontiersin.org/articles/10.3389/fmed.2024.1302637/fullchronic kidney diseaseLC–MS/MSsalivary proteomicbiomarkerPI-PLCSgsm2
spellingShingle Bianca Uliana Picolo
Nathália Rabello Silva
Mário Machado Martins
Hebréia Oliveira Almeida-Souza
Letícia Cristina Machado de Sousa
Richard Costa Polveiro
Luiz Ricardo Goulart Filho
Robinson Sabino-Silva
Vivian Alonso-Goulart
Luciana Saraiva da Silva
Salivary proteomics profiling reveals potential biomarkers for chronic kidney disease: a pilot study
Frontiers in Medicine
chronic kidney disease
LC–MS/MS
salivary proteomic
biomarker
PI-PLC
Sgsm2
title Salivary proteomics profiling reveals potential biomarkers for chronic kidney disease: a pilot study
title_full Salivary proteomics profiling reveals potential biomarkers for chronic kidney disease: a pilot study
title_fullStr Salivary proteomics profiling reveals potential biomarkers for chronic kidney disease: a pilot study
title_full_unstemmed Salivary proteomics profiling reveals potential biomarkers for chronic kidney disease: a pilot study
title_short Salivary proteomics profiling reveals potential biomarkers for chronic kidney disease: a pilot study
title_sort salivary proteomics profiling reveals potential biomarkers for chronic kidney disease a pilot study
topic chronic kidney disease
LC–MS/MS
salivary proteomic
biomarker
PI-PLC
Sgsm2
url https://www.frontiersin.org/articles/10.3389/fmed.2024.1302637/full
work_keys_str_mv AT biancaulianapicolo salivaryproteomicsprofilingrevealspotentialbiomarkersforchronickidneydiseaseapilotstudy
AT nathaliarabellosilva salivaryproteomicsprofilingrevealspotentialbiomarkersforchronickidneydiseaseapilotstudy
AT mariomachadomartins salivaryproteomicsprofilingrevealspotentialbiomarkersforchronickidneydiseaseapilotstudy
AT hebreiaoliveiraalmeidasouza salivaryproteomicsprofilingrevealspotentialbiomarkersforchronickidneydiseaseapilotstudy
AT leticiacristinamachadodesousa salivaryproteomicsprofilingrevealspotentialbiomarkersforchronickidneydiseaseapilotstudy
AT richardcostapolveiro salivaryproteomicsprofilingrevealspotentialbiomarkersforchronickidneydiseaseapilotstudy
AT luizricardogoulartfilho salivaryproteomicsprofilingrevealspotentialbiomarkersforchronickidneydiseaseapilotstudy
AT robinsonsabinosilva salivaryproteomicsprofilingrevealspotentialbiomarkersforchronickidneydiseaseapilotstudy
AT vivianalonsogoulart salivaryproteomicsprofilingrevealspotentialbiomarkersforchronickidneydiseaseapilotstudy
AT lucianasaraivadasilva salivaryproteomicsprofilingrevealspotentialbiomarkersforchronickidneydiseaseapilotstudy